Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Medical News: Medicine, Healthcare, Medical Research, Hospitals, Management

Home | Medical-Newswire.Com:

A.P. Pharma, Inc., (Public, NASDAQ:APPA) PDUFA Date of March 18th Rapidly Approaches for APF530

(EMAILWIRE.COM, March 13, 2010 )NY,NY TapeBeat.Com, the news and research portal for the serious investor is proud to present information regarding A.P. Pharma, Inc., (Public, NASDAQ:APPA) a specialty pharmaceutical company based in Redwood City, California. Its current pipeline utilizes a group of polymeric compounds dubbed Biochronomer as its drug delivery mechanism with a number of advantages over current delivery means. Probably the most important advantage of the Biochronomer system is that the actives (drugs) can be incorporated into a drug matrix by simple physical mixing means that allow injectable gels, microspheres, coatings and strands to be created depending on the necessary application. Each of these different forms is capable of controlling site and speed of the active ingredient delivery without the use of active and sometimes questionable liquids such as solvents in the finished drug product.

Currently there is only one drug approved for both acute and delayed onset CINV via serotonin 5-HT3 antagonists, Palonosetron. Serotonin 5-HT3 antagonists work by blocking the effects of a chemical called serotonin, which is produced in the brain and stomach. They prevent and relieve nausea and vomiting caused by chemotherapy. APF530 works by utilizing its delivery system and the 5-HT3 receptor antagonist, Granisetron, as its active ingredient. Granisetron was approved by the FDA for the treatment of acute onset CINV in 1994. The patent on it expired in 2007, so it is freely available for use in APF530.

An advantage of utilizing a previously-approved active ingredient is that the NDA can be submitted under section 505(b)(2) of the Federal Food, Drug and Cosmetic Act in which the application can rely upon the FDA’s previous safety and efficacy profile for APF530’s active ingredient. For further information on how this may favor approval of APF530 please visit TapeBeat.Com for the full story.

Stephen Ramsey
Philip Runfeldt
Staff Writers

Mr. Ramsey is long APPA

By viewing this information you agree to the disclaimer found on TapeBeat.Com. The opinions expressed are that of the individual contributor(s). Neither the company releasing this information, nor the contributor(s) are associated with the company(s) mentioned or acting on their behalf. Neither TapeBeat.Com nor contributor(s) are certified financial advisor(s) or professional analysts. This is not a solicitation to trade in any security or a recommendation. Please do your own due diligence as, trading could result in loss of your principal.

TapeBeat.Com
Philip Runfeldt
888-209-2749
admin@TapeBeat.Com

Source: EmailWire.com


Medical Sponsors

Health News
Yahoo! News
Yahoo! News: Health News
Health News

CDC: Adults eating less fruit, not enough veggies (AP)
9 Sep 2010 at 10:10am
AP - An apple a day? Apparently not in the United States.


Study: Flamboyant male dancing attracts women best (AP)
9 Sep 2010 at 8:52am

AP - John Travolta was onto something. Women are most attracted to male dancers who have big, flamboyant moves similar to the actor's trademark style, British scientists say in a new study.


Doctors see eye hazard in powerful laser pointers (AP)
8 Sep 2010 at 4:54pm
AP - A 15-year-old boy damaged his eyes while playing with a laser pointer he'd bought over the Internet, say doctors who warn that dangerously high-powered versions are easily available online.

Group backs mandatory flu shots for health workers (AP)
8 Sep 2010 at 2:06pm
AP - Flu vaccination should be required for all doctors, nurses and other health workers, the nation's largest pediatricians' group says, calling it a long overdue step to protect patients.

CVS Caremark to give away up to $5M in flu shots (AP)
8 Sep 2010 at 6:51am
AP - CVS Caremark Corp. said Wednesday it will give away up to $5 million in seasonal flu vaccinations to people without health insurance.


AP Exclusive: Back to work after salmonella case (AP)
8 Sep 2010 at 12:18pm

AP - The peanut industry executive whose filthy processing plants were blamed in a salmonella outbreak two years ago that killed nine people and sickened hundreds more is back in the business.


Obesity May Up Death Risk in Older Women With Colon Cancer (HealthDay)
9 Sep 2010 at 9:02am
HealthDay - THURSDAY, Sept. 9 (HealthDay News) -- Here's yet another reason to avoid obesity throughout your life: Doing so may improve your chances of survival if you're diagnosed with colon cancer.


Doctors alarmed by HIV risk for European gays (AFP)
8 Sep 2010 at 4:06pm

AFP - Homosexual men in Europe are increasingly failing to adhere to safe sex, according to two new studies. In France, transmission of the AIDS virus "seems to be out of control" among men who have sex with men, said a paper published on Thursday in The Lancet Infectious Diseases.


Clinical Trials Update: Sept. 9, 2010 (HealthDay)
9 Sep 2010 at 9:02am
HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Smoking Could Harm Sperm, Study Finds (HealthDay)
9 Sep 2010 at 9:02am
HealthDay - THURSDAY, Sept. 9 (HealthDay News) -- Two new studies provide evidence that smoking can harm sperm - both in smoking men who may become fathers, and in sons born to women who smoked during pregnancy.

More doctors no panacea for U.S. healthcare: report (Reuters)
9 Sep 2010 at 9:43am
Reuters - Medicare patients with more doctors to choose from do not necessarily get more or better care, researchers reported on Thursday in an analysis demonstrating how complicated U.S. healthcare reform will be.

Merck schizophrenia drug approved for 2 new uses (AP)
7 Sep 2010 at 12:57pm
AP - Merck & Co. said Tuesday its schizophrenia drug Saphris has been approved for two additional uses by the Food and Drug Administration.

Developers of cancer pill tout biopsy/tweak method (Reuters)
9 Sep 2010 at 4:36am
Reuters - Tests of tumor samples taken before and after treatment with an experimental melanoma pill helped researchers find the right dose in early stage testing, an approach that may boost the drug's chances of success and aid in developing others, company researchers said on Tuesday.

J&J launches aid program for women, children (Reuters)
9 Sep 2010 at 8:28am
Reuters - Johnson & Johnson has pledged grant money, drugs and research funding for new HIV and tuberculosis medications as part of a five-year, private sector effort to improve the health up to 120 million women and children in developing nations each year.


India not treating AIDS patients early: Global Fund (Reuters)
9 Sep 2010 at 8:29am

Reuters - Thousands of AIDS patients in India are not receiving treatment on time, underscoring huge challenges the country faces as it combats the disease, the Global Fund To Fight AIDS, Tuberculosis and Malaria said on Thursday.


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

 Web    News    PressReleases    Feeds    Images    Video    Blogs    Open Directory    Wikipedia    Dictionary    Forums    Shopping 
    
:: Home: :: Submit Press Release :: Subscribe to News :: Shop Online :: Contact Us :: Help

For unlimited press release distribution for $59 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com.
Copyright 2008 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC